1
Total investments
0
Early stage
1
Mid stage
0
Late stage
4y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
2022
Alto Neuroscience is redefining psychiatry by leveraging individuals neurobiology to develop personalized and highly effective medicines, helping patients get better faster.
Altos Precision Psychiatry Platform™ measures biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to match patients with the treatment they are most likely to respond to. Our approach matches the right patient with the right Alto drug based on AI-derived brain biomarkers, redefining psychiatry at a time when the world needs it most.
Experience · 2 entries
All (2)
Investments (1)
Board (1)
2022
Board Member
2022
Alto Neuroscience is redefining psychiatry by leveraging individuals neurobiology to develop personalized and highly effective medicines, helping patients get better faster.
Altos Precision Psychiatry Platform™ measures biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to match patients with the treatment they are most likely to respond to. Our approach matches the right patient with the right Alto drug based on AI-derived brain biomarkers, redefining psychiatry at a time when the world needs it most.
2019
Venture Partner
Jan 2019
The heart of SiFive is RISC-V! SiFive creates the building blocks of RISC-V-based IP that are the inevitable innovative reimagining of every computing platform.